Impact of Virtual Reality on Anxiety in Patients Undergoing Interventional Procedures

Purpose

Periprocedural anxiety is a common problem for patients who undergo interventional pain procedures. Virtual Reality (VR) is an immersive experience that has gained acceptance in the medical field as a tool for reducing anxiety and pain for patients.Research Aim: To evaluate the effect of immersive virtual reality (VR) on periprocedural anxiety related to therapeutic cervical epidural steroid injections (ESI). The investigators hypothesize that immersive virtual reality will result in a clinically meaningful anxiety reduction, defined as the proportion of participants with > 50% reduction in Numeric Rating Scale (NRS) anxiety scores when compared to participants in the non-treatment group who will have standard preprocedural waiting time conditions in clinic, but no VR experience. Similarly, the investigators hypothesize a significant reduction in objective sympathetic tone as measured by skin sympathetic nerve activity (SKNA).

Condition

  • Anxiety

Eligibility

Eligible Ages
Between 18 Years and 80 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age 18-80 years old at day of enrollment - Neck pain patient deemed to be a candidate for pain control treatment with interventional fluoroscopically guided cervical epidural steroid injection as determined by their pain medicine provider based on history, physical exam, and radiographic findings - Willingness to undergo pre-procedural intervention of VR viewing experience or equivalent pre-procedural wait time - No history of prior epidural steroid injections - Did not receive sedatives prior to or during procedure

Exclusion Criteria

  • Refusal / inability to participate or provide consent - Contraindications to injection (anticoagulated states, allergy to components of injection, local infection at injection site, current infectious process or treatment of antibiotics for current infection) - Uncontrolled anxiety disorder or untreated/inadequately treated psychiatric disorder - History of Alzheimer's, dementia, or cognitive dysfunction - Patient currently taking benzodiazepines - Severe motion sickness - Seizure disorder - Vision loss - Non-English speaking patients

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Intervention Model Description
Randomized controlled observational trial
Primary Purpose
Other
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Group 1 Immersive Virtual Reality (VR)
Participants in Group 1 Immersive Virtual Reality (VR) will wear the device covering their eyes. The viewing experience will include calming nature sounds for between 15-20 minutes before their planned plain clinic procedure.
  • Other: Group 1 Immersive Virtual Reality (VR)
    Participants in Group 1 Immersive Virtual Reality (VR) participants wear the device covering their eyes. The viewing experience will include calming nature sounds for between 15-20 minutes before their planned plain clinic procedure
Placebo Comparator
Group 2 control group
Group 2 control group has no preprocedural intervention. Standard clinic waiting conditions for 15-20 minutes before their planned pain clinic procedure.
  • Other: Group 2 Control Group
    Group 2 control group participants have no preprocedural intervention. Standard clinic waiting conditions for 15-20 minutes before their planned pain clinic procedure.

Recruiting Locations

More Details

Status
Recruiting
Sponsor
Northwestern University

Study Contact

Paul Fitzgerald, RN,BSN,MS
312-695-1064
p-fitzgerald2@northwestern.edu